---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-21-062296"
form_type: "8-K"
ticker: "EMMA"
cik: "0000822370"
company_name: "Emmaus Life Sciences, Inc."
filed_at: "2021-11-29T23:59:59+00:00"
generated_at: "2026-06-28T05:14:16.003914+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Emmaus shareholders approve reverse split authorization and 2021 stock plan

## Summary
- Reverse stock split authorization approved: 29,399,449 for, 540,130 against, 90,183 withheld.
- 2021 Stock Incentive Plan approved: 25,609,777 for, 433,820 against, 36,796 withheld.
- Seven directors elected: Yutaka Niihara, Willis C. Lee, Robert Dickey IV, Masaharu Osato, Jane Pine Wood, Wei Peu Zen, Alfred Lui.
- Advisory say-on-pay vote approved: 25,543,032 for, 497,065 against; board set frequency at every three years.
- Baker Tilly US, LLP ratified as independent auditor for FY2021: 29,935,626 for, 44,800 against.

## SEC filing metadata
- accession: 0001213900-21-062296
- form_type: 8-K
- ticker: EMMA
- cik: 0000822370
- company_name: Emmaus Life Sciences, Inc.
- filed_at: 2021-11-29T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/822370/000121390021062296/0001213900-21-062296-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/822370/000121390021062296/ea151382-8k_emmauslife.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-21-062296
- JSON: https://secwatch.observer/filing/0001213900-21-062296.json
- Plain text: https://secwatch.observer/filing/0001213900-21-062296.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.